Fortis Group Advisors, LLC Bristol Myers Squibb CO Transaction History
Fortis Group Advisors, LLC
- $543 Billion
- Q1 2024
A detailed history of Fortis Group Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fortis Group Advisors, LLC holds 500 shares of BMY stock, worth $20,560. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 3,984
87.45%
Holding current value
$20,560
Previous $258 Million
89.49%
% of portfolio
0.0%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,552Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.65 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.68 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.77 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.65 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.89 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $87.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...